Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA4 | P22748 | 1/20 | 0.41 |
| ▸ | LTA4H | P09960 | 2/20 | 0.40 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.37 |
| ▸ | TP53 | P04637 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
| ▸ | NPC1 | O15118 | 2/20 | 0.36 |
| ▸ | RAB9A | P51151 | 2/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.36 |
| ▸ | LMNA | P02545 | 1/20 | 0.36 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.36 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.36 |
| ▸ | CA12 | O43570 | 1/20 | 0.35 |
| ▸ | CA1 | P00915 | 1/20 | 0.35 |
| ▸ | CA2 | P00918 | 1/20 | 0.35 |
| ▸ | CA7 | P43166 | 1/20 | 0.35 |
| ▸ | CA9 | Q16790 | 1/20 | 0.35 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.35 |
| ▸ | CES2 | O00748 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3144432 | 1.00 | CA4 (0.41) | CA4LTA4HTRPA1TP53KMT2A | |
| SCHEMBL1002708 | 1.00 | CA4 (0.41) | CA4LTA4HTRPA1TP53KMT2A | |
| SCHEMBL3130436 | 1.00 | CA4 (0.41) | CA4LTA4HTRPA1TP53KMT2A | |
| SCHEMBL3128960 | 0.86 | TSHR (0.38) | CA4TP53KMT2ANPC1RAB9A | |
| SCHEMBL10013052 | 0.86 | — | — | |
| SCHEMBL759758 | 0.84 | — | — | |
| SCHEMBL3139845 | 0.83 | KIF11 (0.31) | — | |
| SCHEMBL3137195 | 0.83 | CA4 (0.50) | CA4LTA4HTRPA1TP53NPC1 | |
| SCHEMBL758606 | 0.83 | CA4 (0.50) | CA4LTA4HTRPA1TP53NPC1 | |
| SCHEMBL4340775 | 0.82 | CA4 (0.59) | CA4LTA4HTRPA1NPC1RAB9A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 29 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9057018-B2 | Polymerizable liquid crystal compound, polymerizable liquid crystal composition, and polymer thereof | JNC CORPORATION (JP) | 2015-06-16 | — | — | US | disclosed |
| US-8455061-B2 | Optically active compound having polymerizable group and its polymer | JNC CORPORATION (JP) | 2013-06-04 | — | — | US | disclosed |
| US-8419972-B2 | Polymerizable liquid crystal composition | JNC CORPORATION (JP) | 2013-04-16 | — | — | US | disclosed |
| US-8420764-B2 | Compound having silsesquioxane skeleton and its polymer | JNC CORPORATION (JP) | 2013-04-16 | — | — | US | disclosed |
| US-8404316-B2 | Polymerizable liquid crystal compound and its polymer | JNC CORPORATION (JP) | 2013-03-26 | — | — | US | disclosed |
| US-8366962-B2 | Polymerizable liquid crystal compounds having oxiranyl group, polymerizable liquid crystal compositions and polymers | JNC CORPORATION (JP) | 2013-02-05 | — | — | US | disclosed |
| US-8354147-B2 | Polymerizable liquid crystal compound, composition and polymer | JNC CORPORATION (JP) | 2013-01-15 | — | — | US | disclosed |
| US-8236917-B2 | Compound having silsesquioxane skeleton and its polymer | JNC CORPORATION (JP) | 2012-08-07 | — | — | US | disclosed |
| US-20120178894-A1 | COMPOUND HAVING SILSESQUIOXANE SKELETON AND ITS POLYMER | INAGAKI JYUN-ICHI (JP) | 2012-07-12 | — | — | US | disclosed |
| US-20110240918-A1 | OPTICALLY ACTIVE COMPOUND HAVING POLYMERIZABLE GROUP AND ITS POLYMER | CHISSO CORPORATION (JP) | 2011-10-06 | — | — | US | disclosed |
| US-7425354-B2 | Photopolymerizable liquid crystal composition, its polymer or polymer composition, and optical compensation element | CHISSO CORPORATION (JP) | 2008-09-16 | — | — | US | disclosed |
| US-7407691-B2 | Photopolymerizable oxetane derivative and liquid-crystal composition containing it | CHISSO CORPORATION (JP) | 2008-08-05 | — | — | US | disclosed |
| US-7381350-B2 | Fluorene derivatives and polymers thereof | CHISSO CORPORATION (JP) | 2008-06-03 | — | — | US | disclosed |
| US-20070190344-A1 | Verification of translation | JNC CORPORATION (JP) | 2007-08-16 | — | — | US | disclosed |
| US-7101595-B2 | Photo-curable fluorene derivative and composition containing the same | CHISSO CORPORATION (JP) | 2006-09-05 | — | — | US | disclosed |
| US-20060006364-A1 | Fluorene derivatives and polymers thereof | CHISSO CORPORATION AND CHISSO PETROCHEMICAL CORPORATION | 2006-01-12 | — | — | US | disclosed |
| US-20050224757-A1 | Photopolymerizable oxetane derivative and liquid-crystal composition containing it | JNC PETROCHEMICAL CORPORATION (JP) | 2005-10-13 | — | — | US | disclosed |
| US-20050213009-A1 | Photopolymerizable liquid crystal composition, its polymer or polymer composition, and optical compensation element | JNC PETROCHEMICAL CORPORATION (JP) | 2005-09-29 | — | — | US | disclosed |
| US-20050031801-A1 | Photo-curable fluorene derivative and composition containing the same | JNC PETROCHEMICAL CORPORATION (JP) | 2005-02-10 | — | — | US | disclosed |
| US-20050009982-A1 | Compound having silsesquioxane skeleton and its polymer | CHISSO CORPORATION (JP) | 2005-01-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20050009982-A1 | Compound having silsesquioxane skeleton and its polymer | C1S, H1-4, H1-0 | CA4 97/4885LTA4H 2546/4885TRPA1 117/4885 |
| US-20050224757-A1 | Photopolymerizable oxetane derivative and liquid-crystal composition containing it | TAC3, CPNE4, CNPY3 | CA4 263/4885LTA4H 318/4885TRPA1 653/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.